Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants

• Ngā kaituhi matua: Jin-Woo Park (Author), Hyewon Chung (Author), Jong-Min Kim (Author), Na Young Kim (Author), Sung Hee Hong (Author), Kyoung-Ah Kim (Author), Ji-Young Park (Author)
• Hōputu: Pukapuka
• I whakaputaina: Adis, Springer Healthcare, 2024-05-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Abstract Background and Objective This study aimed to assess and compare the pharmacokinetics, safety, and tolerability of a fixed-dose combination product (FDCP) comprising four different drugs (two antihypertensive drugs, amlodipine and losartan, and two lipid-lowering agents, ezetimibe and rosuva...